Medical International Technologies Inc. is focused on developing, producing, marketing and selling needle-free jet injectors both for humans and animals. The company provides many different, professional, state-of-the-art needle-free injection systems that eliminate almost all of the problems associated with today’s needle delivery systems.
MIT injectors are fully protected and have already received European Union certification (CE Marking), Health Canada certification (Canadian Medical Device Conformity Assessment System), and full International Organization for Standardization certification (ISO 9001 & 13485 certification) for human use. The company’s devices are currently sold and in use in multiple countries, including the USA, Canada, Australia, England, Holland, China, Malaysia, and Singapore.
MIT has been considerably expanding financial resources in R&D over the past 5 years, having spent several millions of dollars. President and CEO Karim Menassa believes that the market is there, ready, and largely untapped and that his company has a unique technology to significantly penetrate the market.
About QualityStocks:
QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.
Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment